Cornerstone Financial Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.7K Buy
82
+34
+71% +$6.5K 0.01% 304
2026
Q1
$8.8K Buy
48
+9
+23% +$1.66K 0.01% 342
2025
Q4
$6.86K Buy
+39
New +$6.37K 0.01% 358

Other funds holding BIIB

Cornerstone Financial Management's BIIB Position: Q2 2026 in Review

Cornerstone Financial Management increased its Biogen (BIIB) stake by 71% in Q2 2026, buying an estimated $6.5K and bringing the position to 82 shares worth $17.7K. The position accounts for 0.01% of the portfolio, ranked #304.

Cornerstone Financial Management first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Cornerstone Financial Management held 82 shares of Biogen worth $17.7K as of Q2 2026.
  • Cornerstone Financial Management bought 34 Biogen shares in Q2 2026, an estimated $6.5K.
  • Biogen made up 0.01% of Cornerstone Financial Management's portfolio in Q2 2026, its #304 holding.
  • Cornerstone Financial Management first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Cornerstone Financial Management's 13F filing for Q2 2026, filed 12 Aug 2026.